#DaiichiSankyo #ADCs #ADClaunches #Enhertu #Datroway #breastcancer #Oncology #antibodydrugconjugates #trastuzumabderuxtecan #datopotamabderuxtecan #pertuzumab #earlystagebreastcancer #triplenegativebreastcancer #Ifinatamabderuxtecan #IDXd #TROPIONBreast05study #ADCtechnology
zurl.co/TySHW
Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC - Paolo Tarantino
@ptarantinomd.bsky.social
oncodaily.com/voices/datop...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #TROPIONBreast02 #Datroway
Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer
@astra-zeneca.bsky.social
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #Datroway
#breastcancer #triplenegativebreastcancer #TNBC #AstraZeneca #AZ #Datroway #datopotamabderuxtecan #DaiichiSankyo #Oncology #TNBCpatients #TROPIONBreast02trial #metastaticTNBC #immunotherapy #TNBCtumours #Gilead #TROP2ADC #Trodelvy #sacituzumabgovitecan #PFSdata
zurl.co/t8A6T
China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DATROWAY #DatopotamabDeruxtecan #BreastCancer #mBC
Datopotamab Deruxtecan-dlnk (Datroway) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and More
oncodaily.com/drugs/datopo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DatopotamabDeruxtecanDlnk #Datroway #LungCancer @NSCLC
#AstraZeneca and #DaiichiSankyo's TROP2-directed antibody-drug conjugate (#ADC) #Datroway has been granted accelerated approval from the FDA for a #lungcancer indication, seven months after withdrawing an earlier filing for the drug.